GGrantIndex
Sort

46,585 grants matching heart failure

Translational Control in IPF

$458,034
Peter B Bitterman · University Of Minnesota · R01 · FY2008 · HL

Project-002

$458,029
Hind Lal · University Of Alabama At Birmingham · R01 · FY2021 · HL

Novel Mechanisms of Cardiac Function and Dysfunction

$458,029
Hind Lal · University Of Alabama At Birmingham · R01 · FY2021 · HL

Precision Medicine Approach to Vitamin D3 Administration in Critical Illness

$457,978
David Evan Leaf · Brigham And Women'S Hospital · R01 · FY2020 · HL

Placental Senescence in Peripartum Cardiomyopathy

$457,978
Jason David Roh · Massachusetts General Hospital · R01 · FY2024 · HL

The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation.

$457,907
Jonathan Paul Singer · University Of California, San Francisco · U01 · FY2022 · HL

Targeting pathologic G-protein signaling in cardiac and kidney fibrosis

$457,882
Prasad Devarajan · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · HL

Urine Cadmium and Risk of Cardiovascular Disease

$457,844
Jaymie R Meliker · State University New York Stony Brook · R01 · FY2018 · ES

Proteome and Transcriptome Markers of Hypertension in Urine and Plasma Exosomes

$457,820
Kevin L Schey · Vanderbilt University · RC1 · FY2009 · HL

Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung

$457,781
Daniel Stuart Talmor · Beth Israel Deaconess Medical Center · U01 · FY2017 · HL

Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung

$457,781
Daniel Stuart Talmor · Beth Israel Deaconess Medical Center · U01 · FY2020 · HL

Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung

$457,781
Daniel Stuart Talmor · Beth Israel Deaconess Medical Center · U01 · FY2019 · HL

Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung

$457,781
Daniel Stuart Talmor · Beth Israel Deaconess Medical Center · U01 · FY2016 · HL

Cardiac Cell Entry-Inhibition and Protection Therapy for Chronic Chagas Disease

$457,750
Mercio A Pereiraperrin · Tufts University Boston · R01 · FY2015 · AI

Cardiac Cell Entry-Inhibition and Protection Therapy for Chronic Chagas Disease

$457,750
Mercio A Pereiraperrin · Tufts University Boston · R01 · FY2017 · AI

Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus

$457,744
Kelly M. Hines · University Of Georgia · R01 · FY2024 · AI

Mechanism of Skeletal Muscle Calcium Dysregulation in Myotonic Dystrophy

$457,741
John D. Lueck · University Of Rochester · R01 · FY2024 · AR

Training in Cardiovascular Translational Research

$457,663
Andrew R Marks · Columbia University Health Sciences · T32 · FY2017 · HL

Community-Based Evaluation of Sudden Cardiac Death in Hispanics/Latinos

$457,645
Sumeet S Chugh · Cedars-Sinai Medical Center · R01 · FY2023 · HL

Autophagy, cardioprotection and metabolic syndrome

$457,580
Robert M Mentzer · Cedars-Sinai Medical Center · P01 · FY2014 · HL

PROJECT 3

$457,573
Daniel A Beard · University Of Michigan At Ann Arbor · P50 · FY2015 · GM

The effects of soluble guanylyl cyclase stimulation on perioperative vascular reactivity and organ injury in cardiac surgery trial

$457,557
Marcos G Lopez · Vanderbilt University Medical Center · R01 · FY2023 · HL

The effects of soluble guanylyl cyclase stimulation on perioperative vascular reactivity and organ injury in cardiac surgery trial

$457,557
Marcos G Lopez · Vanderbilt University Medical Center · R01 · FY2025 · HL

Magnesium supplement and vascular health: Machine learning from the longitudinal medical record

$457,519
Qing Zeng · George Washington University · R01 · FY2024 · HL

Myocardial Fibrosis in Hypertensive Adults with and without Chronic Kidney Disease

$457,477
Mirela Aurora Dobre · Case Western Reserve University · R01 · FY2019 · HL